GORAN ANDO
CIK 1110748 · last filed 2026-01-06
GORAN ANDO is a corporate insider who has filed 24 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for EYPT, was dated Jan 6, 2026. Across all open-market trades the lifetime net is +$96.3K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $171.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$171.3K
3
24
$96.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EYPT | Director | 13,150 | $13.03 | $171.3K | $39.8K | 13 | 2026-01-06 |
| Cartesian Therapeutics, Inc. (SELB) Delisted | Director | — | $0.88 | — | $0 | 4 | 2023-01-04 |
| Viskase Holdings, Inc. (ENZN) Delisted | Director | 40,409 | — | — | $56.5K | 7 | 2009-07-06 |
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-06 | EYPT | Grant (A) | — | $0 | EDGAR |
| 2025-01-07 | EYPT | Grant (A) | — | $0 | EDGAR |
| 2024-08-21 | EYPT | Buy (P) | +5,000 | $39.8K | EDGAR |
| 2024-01-09 | EYPT | Grant (A) | — | $0 | EDGAR |
| 2023-06-22 | EYPT | Grant (A) | — | $0 | EDGAR |
| 2023-02-13 | EYPT | Exer (M) | +3,250 | $0 | EDGAR |
| 2023-01-04 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-11 | EYPT | Mixed | +2,750 | $0 | EDGAR |
| 2022-01-05 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-23 | EYPT | Grant (A) | — | $0 | EDGAR |